Life Sciences

Local officials hope that Genzyme's sale to one of the world's leading pharmaceutical companies will mean new...

After months of negotiations, Cambridge-based Genzyme, which has significant operations in Central Massachusetts, agreed to be purchased...

Sunovion Pharmaceuticals Inc., which use to be Sepracor, announced that its schizophrenia treatment drug Latuda has begun...

Genzyme, the Cambridge-based pharmaceutical company with major Central Massachusetts operations, has completed the $265 million sale of...

French drug maker Sanofi-Aventis has gotten one step closer to acquiring Genzyme Corp., with Genzyme's board authorizing...

On Jan. 4, Qteros, the 50-person biofuel-development startup in Marlborough, announced a strategic partnership with an Indian...

Generex Biotechnology Corp., which owns Worcester's Antigen Express Inc., has received a $3 million cash infusion. Investors...

Worcester biotech company ECI Biotech received a $13,000 grant from the state to provide funds to train...

French drug maker Sanofi-Aventis SA has extended its offer to buy Cambridge-based biotech giant Genzyme Corp. for...

Nuclea Biotechnologies Inc. of Worcester and Pittsfield is joining with Boston Medical Center in an effort to...

1...134135136...159 Page 135 of 159

Get our email newsletters

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Business news, insights, and data on the companies, people, and trends shaping Central Massachusetts, and beyond.